ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 127

Clinical Application Of Pain Diagrams In Fibromyalgia

Amanda Steele1, Dana Dailey2 and Kathleen Sluka2, 1Rheumatology, University of Iowa Hospitals and Clinics, Iowa City, IA, 2Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: fibromyalgia, measure and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibromyalgia is a condition characterized by chronic widespread pain.  Accurately assessing the subjective experience of pain using objective measures remains a challenging clinical problem, particularly among patients with Fibromyalgia. Commonly utilized self-report pain measures are often time consuming (completing and scoring), potentially decreasing their clinical utility. The current study sought to establish a reliable scoring method of pain diagrams completed by patients with primary fibromyalgia.

Methods: Prior to data collection, IRB approval was received and written consent was obtained. 43 people with fibromyalgia (42 female, 1 male), aged 25-76 years, completed this study (duration of fibromyalgia 7.55 years; range 0.25 to 20 years). Subjects filled out the Fibromyalgia Impact Questionnaire (FIQ), McGill Pain Questionnaire (MPQ) and a visual analog scale (0-10) for pain at rest and movement (walking).  Patients were instructed to mark a body diagram showing areas of pain. To assess inter-rater reliability, a scoring protocol, which included applying a transparent overlay to each patient’s diagram, was designed and tested. A score of 0-46 was assigned to each diagram, based on the number of areas marked.  Ten randomly selected diagrams were scored independently by two raters three times and inter-rater reliability assessed (intraclass correlation, ICC).  The number of body areas was correlated with pain, FIQ, and MPQ scores (Pearson’s, *p=0.05, **p=0.01).

Results: Means ± SEM:  Average pain at rest was 4.39 ± 0.39, pain with movement was 5.23 ± 0.39, FIQ was 58.17 ± 2.24 and MPQ was 44.93 ± 2.5. Scores on the body diagram (n=43) averaged 16.55 ± 1.3 (95% CI 13.92 to 19.18) with the most common areas as neck (91%), shoulders (81%), and low back (63%).  Inter-rater reliability for the body diagram scoring was excellent (ICC=0.952; 95% CI 0.912 to 0.974). Higher scores on the body diagram significantly correlated with higher scores on MPQ (R2= 0.44**), pain at rest (R2=0.324*), pain with movement (R2=0.380*) but not FIQ (R2=0.298).

Conclusion: Preliminary results indicate this protocol may be a reliable method of scoring pain diagrams among patients with Fibromyalgia and that higher scores significantly correlated with worse pain but not the impact of pain on function and quality of life (movement-pain, FIQ). These diagrams provide a quick, simple and clinically applicable self-report measure that can be completed and scored in a very brief period of time. Thus, quantitative analysis of the body diagram may be useful to gain an understanding of the severity of pain but not the global impact of pain as measured by the FIQ.


Disclosure:

A. Steele,
None;

D. Dailey,
None;

K. Sluka,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-application-of-pain-diagrams-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology